Skip to main content

Table 1 Clinicopathological features of 33 patients with pancreatic serous cystadenoma

From: Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens

Clinicopathological features

Variables

n (%)

Age (median, range)

63 years (23–87)

Gender

Male

10 (30%)

Female

23 (70%)

Specimen type

Surgical resection

23 (70%)

EUS cytology

10 (30%)

Location

Head

8 (24%)

Body

16 (48%)

Distal

8 (24%)

Diffuse

1 (3%)

Cyst size (median, range)

2.6 cm (0.3–7.5)

 

Cyst fluid CEA level (n = 11)

Normal (< 5 ng/mL)

9 (82%)

Elevated (> = 5 ng/mL)

2 (18%)

Cyst types

Microcystic

26 (79%)

Macrocytic/oligocystic

7 (21%)

von Hippel-Lindau syndrome

Yes

6 (18%)

No

27 (82%)

Patient follow-up for EUS cytology cases (n = 10)

No follow-up available

2 (20%)

Died of other disease(s)

2 (20%)

Stable and asymptomatic

6 (60%)